Navigation Links
Jazz Pharmaceuticals to Present at Investor Conferences
Date:11/4/2008

PALO ALTO, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the company will present at three upcoming investor conferences.

On Tuesday, November 11, 2008 at 2:50 p.m. EST, Dr. Samuel R. Saks, Jazz Pharmaceuticals' CEO, will provide a corporate presentation at the Rodman & Renshaw 10th Annual Healthcare Conference in New York City.

On Wednesday, November 12, 2008 at 3:30 p.m. MST (5:30 p.m. EST), Dr. Saks will provide a corporate presentation at the Credit Suisse Healthcare Conference in Phoenix.

On Wednesday, November 19, 2008 at 11:30 a.m. EST, Robert M. Myers, President of Jazz Pharmaceuticals, will provide a corporate presentation at the Lazard Capital Markets 5th Annual Healthcare Conference in New York City.

A live webcast of these presentations may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on the site for two weeks following each presentation.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
2. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
3. MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
4. Pacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes
5. Genesis Pharmaceuticals Files Counter Claims
6. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
7. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
8. MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results
9. ISTA Pharmaceuticals Reports Third Quarter 2008 Financial Results
10. ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
11. Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Utah (PRWEB) , ... January 17, 2017 , ... ... of accredited, online continuing education for EMS and firefighting professionals, has released four ... (VILT) Solution. These new courses are taught live in an online classroom and ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... today announced its partnership with Sigfox in the U.S.A. to offer ... nationwide including new offerings on large-scale environmental sensor deployments such as monitoring ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley ... double blind clinical study for its dental gel that shows significant reduction in plaque ... toothpaste containing triclosan. The study was conducted at the Beckman Laser Institute at UC ...
(Date:1/17/2017)... York, NY (PRWEB) , ... January 17, 2017 ... ... Inc. Magazine’s fastest-growing private companies and ranked among the top US security companies ... Board of Directors. This announcement brings a year-long independent board nomination process ...
(Date:1/16/2017)... ... 17, 2017 , ... To provide comfort and fuel during ... fast-casual category, announces a hearty and wholesome Winter Menu. Starting today, guests can ... Sandwich, Cranberry Crunch & Honey Parfait, Slow Cooked Smoky Chicken & Sausage Soup, ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017  Market Research Future published a ... Devices Market is expected to reach USD 33.6 million during the ... Market Highlights ... The Global Endoscopy Devices Market has been examined as a swiftly ... there is huge demand for endoscopy device in various regions.  The ...
(Date:1/17/2017)... YORK , Jan. 17, 2016  Attorney Advertising -- ... behalf of purchasers of Anthera Pharmaceuticals, Inc. ("Anthera" or the ... to obtain additional information and assist the investigation by visiting ... concerns whether Anthera and certain of its officers and/or directors ... Act of 1934. ...
(Date:1/17/2017)...  In a letter to President-elect Donald J. ... outlines AARP,s priorities for Americans age 50 and older ... affordable health care coverage, and lowering the cost of ... to President-elect Trump that "Our nearly 38 million members ... to protect their Medicare and Social Security benefits, protect ...
Breaking Medicine Technology: